Clinical Trials
7 trialsNCT03685591 2024-06-26
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT01234480 2023-05-16
Intended Use Study of the BD SurePath Plusâ„¢ Pap
Becton, Dickinson and Company
Terminated
NCT02376699 2023-05-01
Safety Study of SEA-CD40 in Cancer Patients
Seagen Inc.
Phase 1 Terminated
NCT01142869 2017-05-08
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Merck KGaA, Darmstadt, Germany
Terminated
NCT00272181 2015-12-23
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Sesen Bio, Inc.
Phase 2 Terminated
NCT00412776 2015-12-23
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Sesen Bio, Inc.
Phase 2/3 Terminated
NCT00401401 2011-12-23
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Genmab
Phase 1/2 Terminated